Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
0.00%
SPX
0.00%
IXIC
0.00%
FTSE
-0.15%
N225
-0.56%
AXJO
-0.16%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

AXSM Mark Coleman sells $388K worth of shares

May 30, 2025, 4:36 AM
0.00%
What does AXSM do
Axsome Therapeutics, based in New York City, develops therapies for central nervous system disorders, with commercial products Auvelity and Sunosi, and investigational drugs AXS-05 and AXS-07. The company employs 545 staff and went public in November 2015.
Mark Coleman sold 3,750 shares of AXSM on 28 May at $103.43 per share, worth a total of $388K. They now own 46,637 AXSM shares, or a 7% holding decrease.
📡️ Health Care
Insider Trades

More Signals

Feature in Progress
This section is under development. Check back soon for updates!